Sangamo Therapeutics (SGMO) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Sangamo Therapeutics (SGMO) over the last 17 years, with Q3 2025 value amounting to 0.34.
- Sangamo Therapeutics' Asset Utilization Ratio fell 3323.25% to 0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34, marking a year-over-year decrease of 3323.25%. This contributed to the annual value of 0.43 for FY2024, which is 1058.01% down from last year.
- According to the latest figures from Q3 2025, Sangamo Therapeutics' Asset Utilization Ratio is 0.34, which was down 3323.25% from 0.88 recorded in Q2 2025.
- In the past 5 years, Sangamo Therapeutics' Asset Utilization Ratio ranged from a high of 0.92 in Q4 2023 and a low of 0.11 during Q2 2024
- Over the past 5 years, Sangamo Therapeutics' median Asset Utilization Ratio value was 0.19 (recorded in 2022), while the average stood at 0.37.
- In the last 5 years, Sangamo Therapeutics' Asset Utilization Ratio crashed by 8061.8% in 2024 and then skyrocketed by 69373.81% in 2025.
- Sangamo Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.11 in 2021, then surged by 73.87% to 0.19 in 2022, then surged by 375.59% to 0.92 in 2023, then plummeted by 41.77% to 0.53 in 2024, then plummeted by 35.88% to 0.34 in 2025.
- Its Asset Utilization Ratio stands at 0.34 for Q3 2025, versus 0.88 for Q2 2025 and 0.67 for Q1 2025.